獸醫支架市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年全球獸醫支架市場價值為 4,500 萬美元，預計到 2034 年將以 6.7% 的複合年成長率成長至 8,530 萬美元。由於對微創治療的需求不斷成長、寵物主人意識的不斷提高以及獸醫醫療保健的不斷進步，市場正在不斷擴大。隨著全球寵物數量的不斷增加，對先進、微創治療方案的需求也在增加，以確保更快的康復和更少的併發症。支架材料和放置技術的改進等技術創新正在徹底改變小動物的護理，特別是那些需要精確手術才能獲得長期功能的動物。

這些發展，特別是在支架中使用鎳鈦合金和生物相容性聚合物，顯著改善了動物呼吸、血管和泌尿疾病的治療。獸醫專業人員現在能夠處理複雜病例，風險更低，恢復結果更可預測，使支架植入手術得到更廣泛的接受。隨著增強型螢光透視和內視鏡技術的普及，獸醫醫院和診所現在更有能力提供這些程序，從而促進全科診所和專科中心的更廣泛採用。

2024 年，氣道支架領域以 1,770 萬美元的市場規模領先。這種主導地位與小型犬種呼吸系統疾病的日益普及有關，尤其是氣管塌陷（一種導致氣道變窄的疾病）。支架設計的新進展，包括自膨脹形式和可生物分解的選擇，有效地滿足了小動物的獨特需求，最大限度地減少了不適和併發症。隨著寵物主人和獸醫越來越青睞微創治療，對氣道支架的需求持續上升。

2024年，狗類市場佔據60.5%的市佔率。狗更容易被診斷出患有氣道塌陷、血管阻塞和尿道阻塞等慢性疾病，這確保了對獸醫支架的穩定需求。大型犬種通常需要血管或泌尿支持，而小型犬和玩具犬種則面臨更頻繁的呼吸道相關併發症，從而推動了這些產品的使用。

2024 年，北美佔據了 41.5% 的市場佔有率，這得益於寵物擁有量的普及、寵物健康意識的增強以及對先進獸醫治療的日益成長的傾向。該地區擁有強大的獸醫基礎設施，包括配備最先進的診斷和介入工具的專科醫院和急診中心。熟練的專業人員和先進的影像技術（例如透視和 CT 掃描）進一步提高了支架放置的準確性。

市場的主要參與者包括 Dextronix、EpiicVet、AbtVet（Stening Group）、MI Tech、Infiniti Medical、UltraVet Medical Devices、Create Medic 和 TaeWoong Medical。這些公司正在推動支架設計的創新，特別是針對不同物種和情況的自膨脹和可生物分解材料。與獸醫診所和大學合作進行臨床試驗和培訓有助於品牌擴大其市場影響力，而與分銷商建立策略合作夥伴關係、直接聯繫獸醫以及對數位行銷和遠距醫療的投資則加強了其在市場中的地位。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 寵物擁有量不斷上升
    • 呼吸系統和泌尿系統疾病的盛行率
    • 寵物健康和醫療支出意識不斷增強
  • 產業陷阱與挑戰
    • 獸醫支架和手術費用高昂
    • 支架相關併發症的風險
• 成長潛力分析
• 監管格局
• 技術格局
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第5章：市場估計與預測：按產品，2021 - 2034 年

• 主要趨勢
• 氣道支架
• 血管支架
• 尿道支架
• 其他支架

第6章：市場估計與預測：按動物，2021 - 2034 年

• 主要趨勢
• 狗
• 貓
• 其他動物

第7章：市場估計與預測：按應用，2021 - 2034 年

• 主要趨勢
• 氣道塌陷
• 血管阻塞
• 尿路阻塞
• 其他應用

第8章：市場估計與預測：按材料，2021 - 2034 年

• 主要趨勢
• 鎳鈦合金
• 可生物分解聚合物

第9章：市場估計與預測：依最終用途，2021 - 2034 年

• 主要趨勢
• 獸醫醫院和診所
• 其他最終用途

第10章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：公司簡介

• AbtVet (Stening group)
• Create Medic
• Dextronix
• EpiicVet
• Infiniti Medical
• MI Tech
• TaeWoong Medical
• UltraVet Medical Devices

The Global Veterinary Stents Market was valued at USD 45 million in 2024 and is estimated to grow at a CAGR of 6.7% to reach USD 85.3 million by 2034. The market is expanding due to the rising demand for minimally invasive treatments, growing awareness among pet owners, and ongoing advancements in veterinary healthcare. As the global pet population continues to increase, so does the need for advanced, less-invasive treatment options that ensure quicker recovery and fewer complications. Technological innovations, such as improvements in stent materials and placement techniques, are revolutionizing care for small animals, especially those requiring precision in surgeries for long-term functionality.

These developments, particularly the use of nitinol and biocompatible polymers in stents, have significantly improved the treatment of respiratory, vascular, and urinary conditions in animals. Veterinary professionals are now able to manage complex cases with fewer risks and more predictable recovery outcomes, making stenting procedures more widely accepted. With better access to enhanced fluoroscopic and endoscopic technology, veterinary hospitals and clinics are now more capable of providing these procedures, fostering broader adoption among general practices and specialized centers.

The airway stents segment led the market with USD 17.7 million in 2024. This dominance is linked to the increasing prevalence of respiratory issues in smaller dog breeds, particularly tracheal collapse, a condition that narrows the airway. New advancements in stent design, including self-expanding formats and biodegradable options, are effectively addressing the unique needs of small animals, minimizing both discomfort and complications. As pet owners and veterinarians increasingly favor less-invasive options, the demand for airway stents continues to rise.

In 2024, the dogs segment accounted for 60.5% of the market share. Chronic conditions such as airway collapse, vascular blockages, and urethral obstructions are more commonly diagnosed in dogs, ensuring steady demand for veterinary stents. Larger dog breeds often require vascular or urinary support, while smaller and toy breeds face more frequent airway-related complications, driving the use of these products.

North America represented 41.5% of the market share in 2024, supported by widespread pet ownership, heightened pet health awareness, and a growing inclination toward advanced veterinary treatments. The region benefits from a robust veterinary infrastructure, including specialty hospitals and emergency care centers equipped with state-of-the-art diagnostic and interventional tools. The availability of skilled professionals and advanced imaging techniques, such as fluoroscopy and CT scans, further enhances the accuracy of stent placement.

Key players in the market include Dextronix, EpiicVet, AbtVet (Stening Group), M.I. Tech, Infiniti Medical, UltraVet Medical Devices, Create Medic, and TaeWoong Medical. These companies are driving innovation in stent design, particularly with self-expanding and biodegradable materials tailored for various species and conditions. Collaborations with veterinary clinics and universities for clinical trials and training are helping brands expand their market presence, while strategic partnerships with distributors, direct outreach to veterinarians, and investments in digital marketing and telemedicine are strengthening their positions in the market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising pet ownership
    • 3.2.1.2 Prevalence of respiratory and urological disorders
    • 3.2.1.3 Growing awareness of pet health and healthcare expenditure
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of veterinary stents and procedures
    • 3.2.2.2 Risk of stent-related complications
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Porter’s analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Airway stents
• 5.3 Vascular stents
• 5.4 Urethral stents
• 5.5 Other stents

Chapter 6 Market Estimates and Forecast, By Animal, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Dogs
• 6.3 Cats
• 6.4 Other animals

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Airway collapse
• 7.3 Vascular obstructions
• 7.4 Urinary tract obstructions
• 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By Material, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Nitinol
• 8.3 Biodegradable polymer

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Veterinary hospitals and clinics
• 9.3 Other end use

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Italy
  • 10.3.5 Spain
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 AbtVet (Stening group)
• 11.2 Create Medic
• 11.3 Dextronix
• 11.4 EpiicVet
• 11.5 Infiniti Medical
• 11.6 M.I. Tech
• 11.7 TaeWoong Medical
• 11.8 UltraVet Medical Devices